IZULAVEM Trademark

Trademark Overview

On Tuesday, July 18, 2023, a trademark application was filed for IZULAVEM with the United States Patent and Trademark Office. The USPTO has given the IZULAVEM trademark a serial number of 98090562. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, June 4, 2025. This trademark is owned by Merck Sharp & Dohme LLC. The IZULAVEM trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, anti-infectives and anti-virals
izulavem

General Information

Serial Number98090562
Word MarkIZULAVEM
Filing DateTuesday, July 18, 2023
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, June 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 7, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, anti-infectives and anti-virals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 16, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck Sharp & Dohme LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRahway, NJ 07065
Party NameMerck Sharp & Dohme LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRahway, NJ 07065

Trademark Events

Event DateEvent Description
Friday, July 21, 2023NEW APPLICATION ENTERED
Wednesday, August 16, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 2, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 7, 2024PUBLISHED FOR OPPOSITION
Wednesday, January 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 3, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, January 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, March 23, 2024ASSIGNED TO EXAMINER
Wednesday, April 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 11, 2024SOU EXTENSION 1 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 4, 2025SOU EXTENSION 2 FILED
Wednesday, June 4, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, June 4, 2025SOU EXTENSION 2 GRANTED
Wednesday, December 11, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, December 11, 2024SOU EXTENSION 1 FILED
Tuesday, August 26, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 26, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 26, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, August 26, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, September 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

izulavem anti infectives virals namely preparations pharmaceutical